Somite rebrands as Cellular Intelligence, advancing virtual cell-signaling model

Somite, an AI-native TechBio company building the first universal virtual cell-signaling model, has rebranded as Cellular Intelligence to reflect the company's vision to understand, predict and control cell behavior.

“While the industry races to map the static geography of cells, we are building the navigation system to guide them. That is the shift our new name represents. By decoding the grammar of cell signaling, we are replacing trial and error with predictive engineering, allowing us to design regenerative therapies and model diseases with the precision of a true engineering discipline. We are building a future where biology is no longer destiny, but design," said Micha Breakstone, Ph.D., co-founder and CEO of Cellular Intelligence.

Cellular Intelligence says its proprietary capsule technology generates dynamic cellular data at over 1,000x higher efficiency than existing methods. The company trains large-scale predictive models on this data to transform biology into an engineering discipline, enabling it to design and optimize regenerative medicine protocols, predict drug responses, and computationally model disease mechanisms.

For regenerative medicine and cell therapy manufacturing, the model can screen countless candidate protocols in silico, predicting which sequence of signals will yield the highest purity of the desired cell type. This enables rational protocol design: instead of blind experimentation, researchers can approach protocol optimization like engineering.